Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Zeng

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
BMC Cancer|November 6, 2023
Association of immune-related adverse events with COVID-19 pneumonia in lung cancer patients receiving immune checkpoint inhibitors: a cross-sectional study in ChinaKaijun Che, Chen Hong, Yanqing He, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2021
Two different patients with pulmonary pleomorphic carcinoma response to PD-1 inhibitor plus anlotinibYuxi Luo, Jianping Wei, Jing Zhang, et al.
Respiratory Research|April 18, 2024
Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functionsYangli Liu, Fengjia Chen, Zhimin Zeng, et al.
BMC Musculoskeletal Disorders|April 12, 2022
The impact of novel anchored barbed suture for capsular closure on hospital length of stay after total knee arthroplasty: a retrospective cohort studyLiming Zhao, Wen Su, Zheyu Huang, et al.
International Immunopharmacology|January 25, 2022
PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse modelYanxin Chen, Yunwei Liu, Xiaoliang Xiong, et al.
Medicine|January 12, 2024
Association between serum C-reactive protein (CRP) and Omicron variant COVID-19 pneumonia in cancer patients: A multicenter cross-sectional study at the end of 2022 in ChinaKaijun Che, Zhimin Zeng, Chen Hong, et al.
Journal of Clinical Pharmacology|October 30, 2022
Immune Checkpoint Inhibitors and Tuberculosis Infection in Lung Cancer: A Case Series and Systematic Review With Pooled AnalysisYanqing He, Duanyang Peng, Pingan Liang, et al.
BMC Pulmonary Medicine|March 15, 2022
Exploration of induced sputum BIRC3 levels and clinical implications in asthmaLijuan Du, Changyi Xu, Zhimin Zeng, et al.
Journal of Translational Medicine|March 15, 2022
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancerYali Yi, Jing Cai, Peng Xu, et al.
Journal of Medical Virology|June 11, 2026
Post-Pandemic Influenza Resurgence in Guangzhou, China: Impact of COVID-19 Interventions and Immune AlterationsJiankai Deng, Qiuping Lin, Zhimin Zeng, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
BMC Cancer|November 6, 2023
Association of immune-related adverse events with COVID-19 pneumonia in lung cancer patients receiving immune checkpoint inhibitors: a cross-sectional study in ChinaKaijun Che, Chen Hong, Yanqing He, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2021
Two different patients with pulmonary pleomorphic carcinoma response to PD-1 inhibitor plus anlotinibYuxi Luo, Jianping Wei, Jing Zhang, et al.
Respiratory Research|April 18, 2024
Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functionsYangli Liu, Fengjia Chen, Zhimin Zeng, et al.
BMC Musculoskeletal Disorders|April 12, 2022
The impact of novel anchored barbed suture for capsular closure on hospital length of stay after total knee arthroplasty: a retrospective cohort studyLiming Zhao, Wen Su, Zheyu Huang, et al.
International Immunopharmacology|January 25, 2022
PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse modelYanxin Chen, Yunwei Liu, Xiaoliang Xiong, et al.
Medicine|January 12, 2024
Association between serum C-reactive protein (CRP) and Omicron variant COVID-19 pneumonia in cancer patients: A multicenter cross-sectional study at the end of 2022 in ChinaKaijun Che, Zhimin Zeng, Chen Hong, et al.
Journal of Clinical Pharmacology|October 30, 2022
Immune Checkpoint Inhibitors and Tuberculosis Infection in Lung Cancer: A Case Series and Systematic Review With Pooled AnalysisYanqing He, Duanyang Peng, Pingan Liang, et al.
BMC Pulmonary Medicine|March 15, 2022
Exploration of induced sputum BIRC3 levels and clinical implications in asthmaLijuan Du, Changyi Xu, Zhimin Zeng, et al.
Journal of Translational Medicine|March 15, 2022
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancerYali Yi, Jing Cai, Peng Xu, et al.
Journal of Medical Virology|June 11, 2026
Post-Pandemic Influenza Resurgence in Guangzhou, China: Impact of COVID-19 Interventions and Immune AlterationsJiankai Deng, Qiuping Lin, Zhimin Zeng, et al.
Pageof 7